GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » EV-to-EBITDA

OrganiGram Holdings (TSX:OGI) EV-to-EBITDA : -0.96 (As of May. 15, 2024)


View and export this data going back to 2011. Start your Free Trial

What is OrganiGram Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, OrganiGram Holdings's enterprise value is C$213.2 Mil. OrganiGram Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-221.0 Mil. Therefore, OrganiGram Holdings's EV-to-EBITDA for today is -0.96.

The historical rank and industry rank for OrganiGram Holdings's EV-to-EBITDA or its related term are showing as below:

TSX:OGI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1024.83   Med: -2.86   Max: 2693.81
Current: -0.97

During the past 10 years, the highest EV-to-EBITDA of OrganiGram Holdings was 2693.81. The lowest was -1024.83. And the median was -2.86.

TSX:OGI's EV-to-EBITDA is ranked worse than
100% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.58 vs TSX:OGI: -0.97

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-15), OrganiGram Holdings's stock price is C$2.48. OrganiGram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-2.998. Therefore, OrganiGram Holdings's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


OrganiGram Holdings EV-to-EBITDA Historical Data

The historical data trend for OrganiGram Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings EV-to-EBITDA Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.84 19.18 69.28 -2.98 -8.60

OrganiGram Holdings Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.93 18.88 17.32 -0.57 -0.44

Competitive Comparison of OrganiGram Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's EV-to-EBITDA falls into.



OrganiGram Holdings EV-to-EBITDA Calculation

OrganiGram Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=213.243/-221.013
=-0.96

OrganiGram Holdings's current Enterprise Value is C$213.2 Mil.
OrganiGram Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-221.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrganiGram Holdings  (TSX:OGI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

OrganiGram Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.48/-2.998
=At Loss

OrganiGram Holdings's share price for today is C$2.48.
OrganiGram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.998.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


OrganiGram Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings (TSX:OGI) Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Executives
Donald Geoffrey Machum Director